GLP-1 Agonists Linked to Obesity-Related Cancer Risk by Diabetes Severity | Retatrutide News

A study links GLP-1 receptor agonists to obesity-related cancer risks, influenced by diabetes severity. This finding is relevant for drugs like Retatrut...
Clinical Trials · November 4, 2026